Urokinase

urokinase-type plasminogen activator (uPA)

The role of soluble urokinase plasminogen activator receptor (suPAR) in the diagnostics of diabetic foot infection.

The role of soluble urokinase plasminogen activator receptor (suPAR) in the diagnostics of diabetic foot infection.

Background: To investigate the role of soluble urokinase plasminogen activator receptor (Supar) in the diagnosis of diabetic foot infection and to determine whether it is superior to other markers of infection such as leukocytes, neutrophils, erythrocyte sedimentation rate, c-reactive protein and procalcitonin.

Methods: This prospective study comprised of four groups: group 1, healthy volunteers (n = 38); Group 2 patients without diabetic foot ulcers (n = 40); Group 3, diabetic patients with foot ulcers that are not infected (n = 33); and Group 4, patients with diabetic foot infections (n ​​= 48). In each group, leukocytes, neutrophils, erythrocyte sedimentation rate, c-reactive protein and procalcitonin and Supar level checked. The results were then statistically compared. Additionally, patients in Group 4 are further divided according to their infection is mild, moderate, and severe. Also osteomyelitis evaluated in Group 4 and statistics compared.

Results: All markers of infection was significantly higher in the group of 4 patients than those in the other three groups (p <0.05). Similarly, all markers of infection in the group of severe diabetic foot infection were statistically higher than the group of mild diabetic foot infection (p <0.05); However, only Supar and the erythrocyte sedimentation rate was significantly higher in cases with osteomyelitis (p <0.05).

In a receiver operating characteristic analysis, the optimal cut-off value for Supar determined to be 2.8 ng / ml, and the sensitivity and specificity above this value was 95.8% and 82.8%, respectively.

Conclusions: This study shows that Supar power is used as a support diagnostic methods for the diagnosis of diabetic foot infection.

The role of soluble urokinase plasminogen activator receptor (suPAR) in the diagnostics of diabetic foot infection.
The role of soluble urokinase plasminogen activator receptor (suPAR) in the diagnostics of diabetic foot infection.

Expression of Urokinase Plasminogen Activator reverse Established Lung Fibrosis.

Disorders plasminogen activation (PA) is causally related to the development of lung fibrosis. previous studies have shown that PA is enhanced in limiting the severity of lung scarring following injury and in vitro studies suggest that PA promotes matrix degradation and fibroblast apoptosis. These findings led us to hypothesize that the increased PA in vivo models will improve the resolution of pulmonary fibrosis was established in conjunction with an increase in myofibroblast apoptosis.

Transgenic C57BL / 6 mice with lung-specific induced urokinase plasminogen activator (uPA) expression doxycycline or treated littermate controls (day 0) with bleomycin or saline. Doxycycline started on day 1, 9, 14, or 21. Lung fibrosis, stiffness, apoptosis, epithelial barrier integrity, and inflammation was assessed. Protection of fibrosis with uPA upregulation of day 1 to day 28 was associated with reduced parenchymal stiffness as determined by atomic force microscopy.

Initiation of uPA expression begins at the end of inflammation or fibrosis initial phase of reduced stiffness and fibrosis on day 28. Induction of uPA activity in mice with established fibrosis lung collagen reduction and stiffness while increasing lung myofibroblast apoptosis. Upregulation of uPA not alter lung inflammation but are associated with increased epithelial cell homeostasis. Returns intrapulmonary PA activity decreased lung fibrogenesis and improve the resolution of established fibrosis of the lungs. This resolution PA-mediated myofibroblast apoptosis is associated with increased and improved epithelial cell homeostasis.

Human HMW Urokinase

MBS135613-5x1mg 5x1mg
EUR 13010

Cytokeratin HMW, AE3

MBS370058-01mLConcentrate 0.1mL(Concentrate)
EUR 225

Cytokeratin HMW, AE3

MBS370058-05mLConcentrate 0.5mL(Concentrate)
EUR 300

Cytokeratin HMW, AE3

MBS370058-1mLConcentrate 1mL(Concentrate)
EUR 440

Cytokeratin HMW, AE3

MBS370058-3mLRTU 3mL(RTU)
EUR 225

Cytokeratin HMW, AE3

MBS370058-7mLRTU 7mL(RTU)
EUR 280

Human Urokinase (HMW)

MBS480672-01mg 0.1mg
EUR 515

Human Urokinase (HMW)

MBS480672-5x01mg 5x0.1mg
EUR 2100

HMW Kininogen Antibody

GWB-2A9222 0.05 mg Ask for price

HMW Kininogen Antibody

GWB-F4CA6A 0.05 mg Ask for price

Cytokeratin HMW 34BE12

MBS370052-01mLConcentrate 0.1mL(Concentrate)
EUR 225

Cytokeratin HMW 34BE12

MBS370052-05mLConcentrate 0.5mL(Concentrate)
EUR 400

Cytokeratin HMW 34BE12

MBS370052-1mLConcentrate 1mL(Concentrate)
EUR 555

Cytokeratin HMW 34BE12

MBS370052-3mLRTU 3mL(RTU)
EUR 245

Cytokeratin HMW 34BE12

MBS370052-7mLRTU 7mL(RTU)
EUR 340

Poly(I).Poly HMW

MBS669116-1mg 1mg
EUR 145

Poly(I).Poly HMW

MBS669116-2mg 2mg
EUR 200

Poly(I).Poly HMW

MBS669116-5x2mg 5x2mg
EUR 890

Poly(I:C) (HMW) Biotin

tlrl-picb 10 µg
EUR 253.05

Poly(I:C) (HMW) Rhodamine

tlrl-picr 10 µg
EUR 253.05

Poly(I:C) (HMW) Fluorescein

tlrl-picf 10 µg
EUR 253.05

Active Rat Urokinase, HMW

MBS135623-005mg 0.05mg
EUR 480

Active Rat Urokinase, HMW

MBS135623-01mg 0.1mg
EUR 775

Active Rat Urokinase, HMW

MBS135623-5x01mg 5x0.1mg
EUR 3265

Active Rat Urokinase, HMW

MBS480800-005mg 0.05mg
EUR 535

Active Rat Urokinase, HMW

MBS480800-5x005mg 5x0.05mg
EUR 2175

WSE-7210 EzFastBlot HMW

2332595 3unit
EUR 64.86
Description: High-Speed for semi-dry high polymer(200kDa<)protein

Kininogen, HMW, Human Plasma

7300-100 each
EUR 438

Kininogen, HMW, Human Plasma

KINH15-N-50 50 ug
EUR 270

Cytokeratin HMW Rabbit mAb

E2R50107 100ul
EUR 385
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Caldesmon / CAD Antibody (HMW)

V7159-100UG 100 ug
EUR 424.15
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody (HMW)

V7159-20UG 20 ug
EUR 186.15
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody (HMW)

V7159IHC-7ML 7 ml
EUR 424.15
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody (HMW)

V7159SAF-100UG 100 ug
EUR 424.15
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody HMW

V3231-100UG 100 ug
EUR 424.15
Description: Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V3231-20UG 20 ug
EUR 186.15
Description: Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V3231SAF-100UG 100 ug
EUR 424.15
Description: Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V7200-100UG 100 ug
EUR 349.3
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody HMW

V7200-20UG 20 ug
EUR 153.3
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody HMW

V7200IHC-7ML 7 ml
EUR 349.3
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody HMW

V7200SAF-100UG 100 ug
EUR 349.3
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody HMW

V7252-100UG 100 ug
EUR 349.3
Description: Caldesmon (CAD, CALD, CALD1) is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). [UniProt]

Caldesmon / CAD Antibody HMW

V7252-20UG 20 ug
EUR 153.3
Description: Caldesmon (CAD, CALD, CALD1) is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). [UniProt]

Caldesmon / CAD Antibody HMW

V7252IHC-7ML 7 ml
EUR 349.3
Description: Caldesmon (CAD, CALD, CALD1) is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). [UniProt]

Caldesmon / CAD Antibody HMW

V7252SAF-100UG 100 ug
EUR 349.3
Description: Caldesmon (CAD, CALD, CALD1) is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). [UniProt]

Caldesmon / CAD Antibody HMW

V2940-100UG 100 ug
EUR 424.15
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody HMW

V2940-20UG 20 ug
EUR 186.15
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody HMW

V2940IHC-7ML 7 ml
EUR 424.15
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody HMW

V2940SAF-100UG 100 ug
EUR 424.15
Description: Caldesmon is an actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity). [UniProt]

Caldesmon / CAD Antibody HMW

V2941-100UG 100 ug
EUR 424.15
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V2941-20UG 20 ug
EUR 186.15
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V2941IHC-7ML 7 ml
EUR 424.15
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V2941SAF-100UG 100 ug
EUR 424.15
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V2942-100UG 100 ug
EUR 424.15
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This mAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V2942-20UG 20 ug
EUR 186.15
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This mAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V2942IHC-7ML 7 ml
EUR 424.15
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This mAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody HMW

V2942SAF-100UG 100 ug
EUR 424.15
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This mAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Active Mouse Urokinase, HMW

MBS135745-005mg 0.05mg
EUR 510

Active Mouse Urokinase, HMW

MBS135745-01mg 0.1mg
EUR 915

Active Mouse Urokinase, HMW

MBS135745-5x01mg 5x0.1mg
EUR 3875

Human Kininogen (HMW) Antibody

20334-05011 150 ug
EUR 175

Cytokeratin HMW(34BE12) Antibody

BNC810446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF680R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC810446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF680R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC430446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF543 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC430446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF543 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC050446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF405M conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC050446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF405M conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC550446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF555 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC550446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF555 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC800446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF680 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC800446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF680 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC610446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF660R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC610446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF660R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC700446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF770 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNC700446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), CF770 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNCP0446-250 250uL
EUR 459.6
Description: Primary antibody against Cytokeratin, HMW(34BE12), PerCP conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNCR0446-250 250uL
EUR 459.6
Description: Primary antibody against Cytokeratin, HMW(34BE12), RPE conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNCA0446-250 250uL
EUR 459.6
Description: Primary antibody against Cytokeratin, HMW(34BE12), APC conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNCAP0446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNCAP0446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNCH0446-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(34BE12) Antibody

BNCH0446-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(34BE12), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Anti-Cytokeratin, HMW antibody

STJ180151 0.1 ml
EUR 254.4

Anti-Cytokeratin, HMW antibody

STJ180152 0.1 ml
EUR 254.4

Cytokeratin(HMW) Monoclonal Antibody

PA6905R-100uL 100uL
EUR 150
Description: Unconjugated

Cytokeratin(HMW) Monoclonal Antibody

PA6905R-200uL 200uL
EUR 260
Description: Unconjugated

Cytokeratin(HMW) Monoclonal Antibody

PA6905R-3mL 3mL
EUR 111
Description: Unconjugated

Cytokeratin(HMW) Monoclonal Antibody

PA6905R-6mL 6mL
EUR 197
Description: Unconjugated

Cytokeratin (HMW) Monoclonal Antibody

MBS2567749-01mL 0.1mL
EUR 195

Cytokeratin (HMW) Monoclonal Antibody

MBS2567749-02mL 0.2mL
EUR 280

Cytokeratin (HMW) Monoclonal Antibody

MBS2567749-3mL 3mL
EUR 165

Cytokeratin (HMW) Monoclonal Antibody

MBS2567749-5x02mL 5x0.2mL
EUR 1225

Cytokeratin (HMW) Monoclonal Antibody

MBS2567749-6mL 6mL
EUR 230

Cytokeratin(HMW) Monoclonal Antibody

RD6905R-100uL 100μL
EUR 225
Description: Cytokeratin (high molecular weight) can recognize cytokeratin 1, cytokeratin 5, cytokeratin 10 and cytokeratin 14. In normal tissues, cytokeratin (high molecular weight) is mainly expressed in squamous epithelium, ductal epithelium and other stratified epithelium. It’s also expressed in lung squamous cell carcinoma, breast cancer, pancreatic cancer, cholangiocarcinoma and bladder transitional cell carcinoma. This antibody can recognize the basal cells of benign prostatic duct, but it is not expressed in prostate cancer. It is often used in combination with p63 and P504S in the judge of prostate cancer.

Cytokeratin(HMW) Monoclonal Antibody

RD6905R-200uL 200μL
EUR 390
Description: Cytokeratin (high molecular weight) can recognize cytokeratin 1, cytokeratin 5, cytokeratin 10 and cytokeratin 14. In normal tissues, cytokeratin (high molecular weight) is mainly expressed in squamous epithelium, ductal epithelium and other stratified epithelium. It’s also expressed in lung squamous cell carcinoma, breast cancer, pancreatic cancer, cholangiocarcinoma and bladder transitional cell carcinoma. This antibody can recognize the basal cells of benign prostatic duct, but it is not expressed in prostate cancer. It is often used in combination with p63 and P504S in the judge of prostate cancer.

Cytokeratin(HMW) Monoclonal Antibody

RD6905R-3mL 3mL
EUR 166.5
Description: Cytokeratin (high molecular weight) can recognize cytokeratin 1, cytokeratin 5, cytokeratin 10 and cytokeratin 14. In normal tissues, cytokeratin (high molecular weight) is mainly expressed in squamous epithelium, ductal epithelium and other stratified epithelium. It’s also expressed in lung squamous cell carcinoma, breast cancer, pancreatic cancer, cholangiocarcinoma and bladder transitional cell carcinoma. This antibody can recognize the basal cells of benign prostatic duct, but it is not expressed in prostate cancer. It is often used in combination with p63 and P504S in the judge of prostate cancer.

Cytokeratin(HMW) Monoclonal Antibody

RD6905R-6mL 6mL
EUR 295.5
Description: Cytokeratin (high molecular weight) can recognize cytokeratin 1, cytokeratin 5, cytokeratin 10 and cytokeratin 14. In normal tissues, cytokeratin (high molecular weight) is mainly expressed in squamous epithelium, ductal epithelium and other stratified epithelium. It’s also expressed in lung squamous cell carcinoma, breast cancer, pancreatic cancer, cholangiocarcinoma and bladder transitional cell carcinoma. This antibody can recognize the basal cells of benign prostatic duct, but it is not expressed in prostate cancer. It is often used in combination with p63 and P504S in the judge of prostate cancer.

Poly(I:C) (HMW) / LyoVec™

tlrl-piclv 100 µg
EUR 169.05

Rat HMW ADNP ELISA Kit

ERA0537 96Tests
EUR 625.2

Goat HMW ADNP ELISA Kit

EGTA0537 96Tests
EUR 625.2

Human HMW ADNP ELISA Kit

EHA0537 96Tests
EUR 625.2

Sheep HMW ADNP ELISA Kit

ESA0537 96Tests
EUR 625.2

Mouse HMW ADNP ELISA Kit

EMA0537 96Tests
EUR 625.2

Bovine HMW ADNP ELISA Kit

EBA0537 96Tests
EUR 625.2

Canine HMW ADNP ELISA Kit

ECA0537 96Tests
EUR 625.2

Poly(I:C) (HMW) VacciGrade™

vac-pic 10 mg
EUR 351.75

Rabbit HMW ADNP ELISA Kit

ERTA0537 96Tests
EUR 625.2

Monkey HMW ADNP ELISA Kit

EMKA0537 96Tests
EUR 625.2

Chicken HMW ADNP ELISA Kit

ECKA0537 96Tests
EUR 625.2

Porcine HMW ADNP ELISA Kit

EPA0537 96Tests
EUR 625.2

Cytokeratin, HMW(34BE12), 0.2mg/mL

BNUB0446-100 100uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Cytokeratin, HMW(34BE12), 0.2mg/mL

BNUB0446-500 500uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Cytokeratin, HMW(34BE12), 1mg/mL

BNUM0446-50 50uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Cytokeratin HMW(AE-3) Antibody

BNC810257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF680R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC810257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF680R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC430257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF543 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC430257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF543 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC050257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF405M conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC050257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF405M conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC550257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF555 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC550257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF555 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC800257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF680 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC800257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF680 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC610257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF660R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC610257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF660R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC700257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF770 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNC700257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), CF770 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCP0257-250 250uL
EUR 459.6
Description: Primary antibody against Cytokeratin, HMW(AE-3), PerCP conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCR0257-250 250uL
EUR 459.6
Description: Primary antibody against Cytokeratin, HMW(AE-3), RPE conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCA0257-250 250uL
EUR 459.6
Description: Primary antibody against Cytokeratin, HMW(AE-3), APC conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCAP0257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCAP0257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCD0257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), Digoxigenin conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCD0257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), Digoxigenin conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCH0257-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(AE-3) Antibody

BNCH0257-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(AE-3), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC811076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF680R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC811076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF680R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC801076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF680 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC801076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF680 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC431076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF543 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC431076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF543 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC051076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF405M conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC051076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF405M conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC551076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF555 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC551076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF555 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC701076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF770 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC701076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF770 conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC611076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF660R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNC611076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), CF660R conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNCP1076-250 250uL
EUR 459.6
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), PerCP conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNCR1076-250 250uL
EUR 459.6
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), RPE conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNCA1076-250 250uL
EUR 459.6
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), APC conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNCH1076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNCH1076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNCAP1076-100 100uL
EUR 238.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Cytokeratin HMW(KRTH/1076) Antibody

BNCAP1076-500 500uL
EUR 652.8
Description: Primary antibody against Cytokeratin, HMW(KRTH/1076), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Caldesmon Antibody / CALD1 / CAD (HMW)

V8878-100UG 100ug
EUR 349.3
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This MAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon Antibody / CALD1 / CAD (HMW)

V8878-20UG 20ug
EUR 153.3
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This MAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon Antibody / CALD1 / CAD (HMW)

V8878SAF-100UG 100ug
EUR 349.3
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This MAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon Antibody / CALD1 / CAD (HMW)

V9402-100UG 100ug
EUR 349.3
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This MAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon Antibody / CALD1 / CAD (HMW)

V9402-20UG 20ug
EUR 153.3
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This MAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon Antibody / CALD1 / CAD (HMW)

V9402SAF-100UG 100ug
EUR 349.3
Description: Recognizes a protein of 150kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. This MAb recognizes only the 150kDa variant (h-caldesmon) in Western blots of human aortic media extracts and is unreactive with fibroblast extracts from cultivated human foreskin. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Human HMW urokinase, HRP conjugate

MBS135617-01mg 0.1mg
EUR 720

Human HMW urokinase, HRP conjugate

MBS135617-1mg 1mg
EUR 4550

HMW Kininogen Light chain Antibody

GWB-5E4F3F 0.05 mg Ask for price

Human HMW urokinase, biotin labeled

MBS135995-01mg 0.1mg
EUR 750

Human HMW urokinase, biotin labeled

MBS135995-1mg 1mg
EUR 4775

Human Kininogen (HMW) Deficient Serum

D131110 1 ml
EUR 65

Caldesmon / CAD Antibody Cocktail (HMW)

V2943-100UG 100 ug
EUR 424.15
Description: Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody Cocktail (HMW)

V2943-20UG 20 ug
EUR 186.15
Description: Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody Cocktail (HMW)

V2943IHC-7ML 7 ml
EUR 424.15
Description: Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Caldesmon / CAD Antibody Cocktail (HMW)

V2943SAF-100UG 100 ug
EUR 424.15
Description: Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80kDa) is found in non- muscle tissue and cells. Neither of the two variants has been detected in skeletal muscle. Caldesmon is a developmentally regulated protein involved in smooth muscle and non-muscle contraction.

Human HMW urokinase, fluorescein labeled

MBS135622-01mg 0.1mg
EUR 720

Human HMW urokinase, fluorescein labeled

MBS135622-1mg 1mg
EUR 4550

Adiponectin glycosilated, HMW Rich Protein

20-abx262998
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 1 mg
  • 2 µg

Adiponectin glycosilated, HMW Rich Protein

abx262998-10mg 10 mg
EUR 325

Adiponectin glycosilated, HMW Rich Protein

abx262998-25mg 25 mg
EUR 7025

Adiponectin glycosilated, HMW Rich Protein

abx262998-5mg 5 mg
EUR 225

Chlamydia trachomatis HMW Protein Antibody

abx411206-02mg 0.2 mg
EUR 678

Chlamydia Trachomatis HMW Protein Antibody

GWB-C632F3 0.2 mg Ask for price

Guinea Pig HMW ADNP ELISA Kit

EGA0537 96Tests
EUR 625.2

Cytokeratin, HMW(AE-3), 0.2mg/mL

BNUB0257-100 100uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Cytokeratin, HMW(AE-3), 0.2mg/mL

BNUB0257-500 500uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Cytokeratin, HMW(AE-3), 1mg/mL

BNUM0257-50 50uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Cytokeratin, HMW(KRTH/1076), 0.2mg/mL

BNUB1076-100 100uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Cytokeratin, HMW(KRTH/1076), 0.2mg/mL

BNUB1076-500 500uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Cytokeratin, HMW(KRTH/1076), 1mg/mL

BNUM1076-50 50uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Anti-AMACR+P63+HMW CK antibody

STJ180008 0.1 ml
EUR 381.6

Anti-AMACR+P63+HMW CK antibody

STJ180270 0.1 ml
EUR 342

These studies support the potential capacity of the lungs to scar finish in murine models.A promising molecular target for aggressive cancer urokinase receptor (Upar). A fully human, recombinant antibodies that bind Upar to form a stable compound that blocks the interaction of uPA-Upar (2G10) and internalized mainly through endocytosis shown efficacy in mouse xenograft models, triple negative breast cancer that is very aggressive (TNBC).

July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  

Recent Posts

Categories

Tags